GW&K Investment Management LLC Sells 69,322 Shares of U.S. Physical Therapy, Inc. $USPH

GW&K Investment Management LLC lowered its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 16.5% in the third quarter, HoldingsChannel reports. The firm owned 350,881 shares of the company’s stock after selling 69,322 shares during the period. GW&K Investment Management LLC’s holdings in U.S. Physical Therapy were worth $29,807,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its position in U.S. Physical Therapy by 68.8% in the third quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after buying an additional 192 shares in the last quarter. Assetmark Inc. raised its stake in shares of U.S. Physical Therapy by 35.7% in the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock valued at $45,000 after acquiring an additional 150 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of U.S. Physical Therapy by 35.3% in the 3rd quarter. Blue Trust Inc. now owns 640 shares of the company’s stock worth $54,000 after acquiring an additional 167 shares in the last quarter. Huntington National Bank grew its position in U.S. Physical Therapy by 71.9% during the 2nd quarter. Huntington National Bank now owns 667 shares of the company’s stock worth $52,000 after acquiring an additional 279 shares during the last quarter. Finally, Fifth Third Bancorp increased its holdings in U.S. Physical Therapy by 38.7% during the 3rd quarter. Fifth Third Bancorp now owns 702 shares of the company’s stock valued at $60,000 after purchasing an additional 196 shares in the last quarter.

U.S. Physical Therapy Trading Down 1.9%

USPH stock opened at $82.49 on Friday. The company has a quick ratio of 1.20, a current ratio of 1.01 and a debt-to-equity ratio of 0.32. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $93.50. The company has a market cap of $1.25 billion, a P/E ratio of 58.09, a PEG ratio of 2.11 and a beta of 1.30. The business has a fifty day moving average of $83.84 and a 200-day moving average of $82.42.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, February 26th. The company reported $0.67 EPS for the quarter, hitting analysts’ consensus estimates of $0.67. The firm had revenue of $202.73 million during the quarter, compared to analyst estimates of $200.10 million. U.S. Physical Therapy had a return on equity of 8.75% and a net margin of 5.07%.The company’s revenue was up 12.3% on a year-over-year basis. During the same period last year, the company earned $0.51 earnings per share. As a group, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 10th. Stockholders of record on Friday, March 13th will be given a dividend of $0.46 per share. The ex-dividend date is Friday, March 13th. This represents a $1.84 annualized dividend and a dividend yield of 2.2%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.45. U.S. Physical Therapy’s dividend payout ratio is presently 126.76%.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. JPMorgan Chase & Co. reduced their price objective on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Monday, November 24th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Finally, Barrington Research restated an “outperform” rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a research report on Friday, February 20th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and an average price target of $105.33.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.